Industry News and Notes – April 2012

Washington Report BIO Submits Comments on FDA Draft Guidances on Biosimilars WASHINGTON, DC — The Biotechnology Industry Organization (BIO) on April 17 submitted comments to the U.S. Food and Drug Administration (FDA) on three draft guidance documents on biosimilar products. “BIO supports the FDA’s ongoing implementation of a science-based pathway for the review and approval… Read the full article


Talent Network Update – April 2012

Top Industry Leaders Featured at BioNJ’s First Life Sciences HR Conference May 14, 2012 • Hilton East Brunswick • 8:00 a.m. to 6:00 p.m. Come Hear Industry Leaders from Top NJ Companies Amicus Therapeutics, Celgene, Covance, Elusys, Hay Group, Merck, Pfizer, PTC Therapeutics, Randstad Professionals, Valeant Pharmaceuticals, and many others Please join us for our… Read the full article


Membership Update – April 2012

BioNJ welcomes Aerie Pharmaceuticals, Inc., and Archimedes Pharma as new Core Members for 2012. Aerie Pharmaceuticals, Inc. Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. All technology of the company is based on internal discovery R&D and is protected by a strong IP… Read the full article


Excitement Building for BioNJ’s Third Annual International BioPartnering Conference

BioNJ’s Third International BioPartnering Conference on May 10-11 at the Westin Princeton at Forrestal Village in Princeton, NJ, is just two weeks away. The excitement is beginning to build as the finishing touches are put into place. With an emphasis on partnering sessions and company presentation opportunities, the Third Annual International BioPartnering Conference will attract… Read the full article


BioNJ Headlines – April 2012

BioNJ’s 2012 Annual Meeting Video Highlights Governor Chris Christie, Roka’s Paul Thomas, and BIO’s Jim Greenwood Moved by the stirring remarks of our special guest speaker, Governor Chris Christie, and breaking all attendance records with more than 700 participants, BioNJ’s 2012 Annual Dinner Meeting, Awards Program and Networking Event was truly a night to remember…. Read the full article


Advocacy Takes Center Stage

We are entering that time of year when legislation and policy are moving fast, and because this year is a Presidential election year, things are moving along at an even more rapid pace than usual. This means that the New Jersey biotech industry needs an advocate — someone to be on the lookout for opportunities… Read the full article